WallStreetZenWallStreetZen

NASDAQ: ANGO
Angiodynamics Inc Stock

$5.70+0.30 (+5.56%)
Updated Mar 27, 2024
ANGO Price
$5.70
Fair Value Price
-$0.18
Market Cap
$227.17M
52 Week Low
$5.26
52 Week High
$12.62
P/E
-16.29x
P/B
0.57x
P/S
0.8x
PEG
N/A
Dividend Yield
N/A
Revenue
$329.54M
Earnings
-$14.12M
Gross Margin
50.7%
Operating Margin
-2.52%
Profit Margin
-4.3%
Debt to Equity
0.25
Operating Cash Flow
-$3M
Beta
0.98
Next Earnings
Apr 4, 2024
Ex-Dividend
N/A
Next Dividend
N/A

ANGO Overview

AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract sealant systems, IsoLoc Endorectal Balloon's, alatus vaginal balloon packing systems, angiographic catheters, guidewires, percutaneous drainage catheters, and coaxial micro-introducer kits. In addition, the company provides endovascular therapies products in the areas of thrombus management, atherectomy, peripheral products (Core), and venous insufficiency. Additionally, the company offers peripherally inserted central catheters, midline catheters, implantable ports, dialysis catheters, and related accessories and supplies that are used primarily to deliver short-term drug therapies, such as chemotherapeutic agents and antibiotics, into the central venous system under the BioFlo, BioFlo Midline, BioFlo PICC, Xcela PICC, PASV, BioFlo Port, SmartPort, Vortex, LifeGuard, BioFlo DuraMax, and DuraMax names. It sells and markets its products to interventional radiologists, interventional cardiologists, vascular surgeons, urologists, interventional and surgical oncologists, and critical care nurses directly, as well as through distributor relationships. The company was founded in 1988 and is headquartered in Latham, New York.

Zen Score

Industry Average (31)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ANGO scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ANGO ($5.70) is overvalued by 3,200.09% relative to our estimate of its Fair Value price of -$0.18 based on Discounted Cash Flow (DCF) modelling
Below Fair Value Valuation
ANGO ($5.70) is not significantly undervalued (3,200.09%) relative to our estimate of its Fair Value price of -$0.18 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
ANGO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more ANGO due diligence checks available for Premium users.

Be the first to know about important ANGO news, forecast changes, insider trades & much more!

ANGO News

Valuation

ANGO fair value

Fair Value of ANGO stock based on Discounted Cash Flow (DCF)
Price
$5.70
Fair Value
-$0.18
Undervalued by
3,200.09%
ANGO ($5.70) is overvalued by... subscribe to Premium to read more.
Below Fair Value Valuation
ANGO ($5.70) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
ANGO is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ANGO price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-16.29x
Industry
53.29x
Market
44.45x

ANGO price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.57x
Industry
3.74x
ANGO is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ANGO's financial health

Profit margin

Revenue
$79.1M
Net Income
-$29.0M
Profit Margin
-36.7%
ANGO's Earnings (EBIT) of -$8.30M... subscribe to Premium to read more.
Interest Coverage Financials
ANGO's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$499.6M
Liabilities
$98.4M
Debt to equity
0.25
ANGO's short-term assets ($185.47M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ANGO's short-term assets ($185.47M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ANGO's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
ANGO's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$5.3M
Investing
-$1.8M
Financing
-$352.0k
ANGO's operating cash flow (-$3.31M)... subscribe to Premium to read more.
Debt Coverage Financials

ANGO vs Medical Stocks

TickerMarket Cap1d %P/EP/B
ANGO$227.17M+5.56%-16.29x0.57x
AKYA$232.44M+2.16%-3.31x4.32x
STXS$206.14M+0.80%-9.30x12.61x
UTMD$251.88M+2.99%15.32x1.96x
INFU$186.42M+3.41%293.33x3.62x

Angiodynamics Stock FAQ

What is Angiodynamics's quote symbol?

(NASDAQ: ANGO) Angiodynamics trades on the NASDAQ under the ticker symbol ANGO. Angiodynamics stock quotes can also be displayed as NASDAQ: ANGO.

If you're new to stock investing, here's how to buy Angiodynamics stock.

What is the 52 week high and low for Angiodynamics (NASDAQ: ANGO)?

(NASDAQ: ANGO) Angiodynamics's 52-week high was $12.62, and its 52-week low was $5.26. It is currently -54.83% from its 52-week high and 8.37% from its 52-week low.

How much is Angiodynamics stock worth today?

(NASDAQ: ANGO) Angiodynamics currently has 39,855,191 outstanding shares. With Angiodynamics stock trading at $5.70 per share, the total value of Angiodynamics stock (market capitalization) is $227.17M.

Angiodynamics stock was originally listed at a price of $13.60 in Jun 1, 2004. If you had invested in Angiodynamics stock at $13.60, your return over the last 19 years would have been -58.09%, for an annualized return of -4.47% (not including any dividends or dividend reinvestments).

How much is Angiodynamics's stock price per share?

(NASDAQ: ANGO) Angiodynamics stock price per share is $5.70 today (as of Mar 27, 2024).

What is Angiodynamics's Market Cap?

(NASDAQ: ANGO) Angiodynamics's market cap is $227.17M, as of Mar 28, 2024.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Angiodynamics's market cap is calculated by multiplying ANGO's current stock price of $5.70 by ANGO's total outstanding shares of 39,855,191.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.